Table 2.
Treatment of Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).
|
|
|---|
| TREATMENT OF ATTR-CM: SUMMARY KEY POINTS |
|
|
|
|
|
| Heart failure |
|
|
| Arrhythmias |
|
|
| Thromboembolism |
|
|
| Orthostatic hypotension |
|
|
| Correction of aortic stenosis and other valvular defects (if indicated) |
|
|
| Heart transplantation/other measures for advanced heart failure |
|
|
|
|
|
| Transthyretin stabilizers |
|
|
| Transthyretin silencers |
|
|
| Other (possible non-genetic and genetic therapies) |
|
|
|
|
|
| Exercise & Nutrition |
|
|
| Vaccines |
|
|
| Individualized approach to physical and emotional patient’s needs |
|
|